Different cell death modes in cancer treatment

被引：0
|
作者：
Bai, Zhaoshi [1 ,2 ,3 ]
Dou, Jie [4 ]
Saleh, Tareq [5 ]
Xu, Jingwen [6 ]
Zhu, Wufu [7 ]
机构：
[1] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Inst Canc Res, Nanjing, Jiangsu, Peoples R China
[3] Nanjing Med Univ, Affiliated Canc Hosp, Nanjing, Jiangsu, Peoples R China
[4] China Pharmaceut Univ, Sch Life Sci & Technol, Nanjing, Jiangsu, Peoples R China
[5] Hashemite Univ, Fac Med, Dept Pharmacol & Publ Hlth, Zarqa, Jordan
[6] Guangdong Pharmaceut Univ, Guangzhou, Peoples R China
[7] Jiangxi Sci & Technol Normal Univ, Nanchang, Peoples R China
来源：
FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷
关键词：
cell death modes; mechanism; interaction; anticancer drugs; drug discovery;
D O I：
10.3389/fphar.2023.1291585
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Interleukin 6 regulates the expression of programmed cell death ligand 1 in thyroid cancer
    Zhang, Guo-Qiang
    Jiao, Qiong
    Shen, Chen-Tian
    Song, Hong-Jun
    Zhang, Hui-Zhen
    Qiu, Zhong-Ling
    Luo, Quan-Yong
    CANCER SCIENCE, 2021, 112 (03) : 997 - 1010
  • [42] Ingenol Mebutate-Induced Cell Death Patterns in Normal and Cancer Epithelial Cells
    Stahlhut, Martin
    Bertelsen, Malene
    Hoyer-Hansen, Maria
    Svendsen, Nannette
    Eriksson, Andre H.
    Lord, Janet M.
    Scheel-Toellner, Dagmar
    Young, Stephen P.
    Zibert, John R.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (10) : 1181 - 1192
  • [43] Enzymatic Assemblies Disrupt the Membrane and Target Endoplasmic Reticulum for Selective Cancer Cell Death
    Feng, Zhaoqianqi
    Wang, Huaimin
    Wang, Shiyu
    Zhang, Qiang
    Zhang, Xixiang
    Rodal, Avital A.
    Xu, Bing
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2018, 140 (30) : 9566 - 9573
  • [44] Therapeutic Efficacy Studies on the Monoterpenoid Hinokitiol in the Treatment of Different Types of Cancer
    Bhuia, Md. Shimul
    Chowdhury, Raihan
    Afroz, Meher
    Akbor, Md. Showkot
    Al Hasan, Md. Sakib
    Ferdous, Jannatul
    Hasan, Rubel
    de Alencar, Marcus Vinicius Oliveira Barros
    Mubarak, Mohammad S.
    Islam, Muhammad Torequl
    CHEMISTRY & BIODIVERSITY, 2025,
  • [45] Cell death mediated by nanotechnology via the cuproptosis pathway: A novel horizon for cancer therapy
    Wei, Chuang
    Fu, Qinrui
    VIEW, 2023, 4 (03)
  • [46] Therapeutic Applications of Programmed Death Ligand 1 Inhibitors in Small Cell Lung Cancer
    Nabipur, Leena
    Mouawad, Michael
    Venketaraman, Vishwanath
    BIOMEDICINES, 2025, 13 (02)
  • [47] Complementary Treatment of Breast Cancer Cells with Different Metastatic Potential with Iscador Qu in the Presence of Clinically Approved Anticancer Drugs
    Iliev, Ivan
    Tsoneva, Iana
    Nesheva, Aleksandrina
    Staneva, Galya
    Robev, Bozhil
    Momchilova, Albena
    Nikolova, Biliana
    CURRENT ISSUES IN MOLECULAR BIOLOGY, 2024, 46 (11) : 12457 - 12480
  • [48] Heterogeneity in tumor cell energetic metabolome at different cell cycle phases of human colon cancer cell lines
    Maddula, Sasidhar
    Baumbach, Joerg Ingo
    METABOLOMICS, 2011, 7 (04) : 509 - 523
  • [49] Synthesis, Cytotoxicity, and Cell Death Profile of Polyaminoanthraquinones as Antitumor Agents
    Wang, Jianhong
    Gao, Ruihong
    Li, Qian
    Xie, Songqiang
    Zhao, Jin
    Wang, Chaojie
    CHEMICAL BIOLOGY & DRUG DESIGN, 2012, 80 (06) : 909 - 917
  • [50] Combined treatment with cotylenin A and phenethyl isothiocyanate induces strong antitumor activity mainly through the induction of ferroptotic cell death in human pancreatic cancer cells
    Kasukabe, Takashi
    Honma, Yoshio
    Okabe-Kado, Junko
    Higuchi, Yusuke
    Kato, Nobuo
    Kumakura, Shunichi
    ONCOLOGY REPORTS, 2016, 36 (02) : 968 - 976
12345